Nureca Ltd (NURECA)
🎯 Key Takeaways
- Nureca Ltd operates as an e-commerce aggregator platform, primarily facilitating transactions for small and mid-sized sellers through its digital marketplace. The company has demonstrated revenue growth over recent quarters, but profitability remains volatile, with alternating periods of operating profit and loss.
- Revenue grew 13.9% QoQ to ₹40 in Q1FY27.
- ⚠️ Profitability remains fragile, with alternating quarters of profit and loss, and no clear path to margin improvement.
- Market Cap
- ₹346
- P/E Ratio
- 84.4
- P/B Ratio
- 1.92
- ROE
- 2.4%
- ROCE
- 5.2%
- Debt/Equity
- 0.00
- Promoter
- 68.1%
📖 The Story
Nureca Ltd operates as an e-commerce aggregator platform, primarily facilitating transactions for small and mid-sized sellers through its digital marketplace. The company has demonstrated revenue growth over recent quarters, but profitability remains volatile, with alternating periods of operating profit and loss. ROE and ROCE are low, reflecting limited capital efficiency, while the absence of debt suggests a conservative capital structure. The company is in a nascent growth phase, with management focusing on scaling transaction volume rather than near-term profitability.
📰 What's Happening
In the last three quarters, Nureca has seen fluctuating revenue and profitability, with June 2026 showing a return to profitability (OP ₹3, NP ₹3) after a loss in March 2026. Management has not announced major strategic shifts, but consistent insider buying by promoter Saurabh Goyal in late September 2026, though procedurally required due to exchange system failures, signals confidence in the company's trajectory. There have been no new product launches, M&A activities, or expansion announcements in recent filings. The core business remains focused on aggregating seller activity through its platform, with growth driven by incremental transaction volume.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 38 | 40 | 35 | 40 |
| Operating Profit | 3 | 3 | -6 | 3 |
| OPM % | 7.3% | 6.9% | -17.6% | 7.0% |
| Net Profit | 4 | 4 | -6 | 3 |
| EPS | ₹3.63 | ₹3.91 | ₹-6.45 | ₹3.21 |
Nureca's financial performance has been inconsistent, with revenue stabilizing around ₹35–40 crore per quarter but profitability swinging between small operating profits and losses. The return to positive operating income in June 2026 suggests some operational stabilization, but margins remain thin (7% OPM). The company continues to reinvest, as seen in negative investing cash flows, though financing activities show net outflows, likely due to share buybacks or settlements. Without sustained margin expansion or revenue acceleration, profitability remains uncertain.
🔮 Management Outlook & What's Next
Management has not provided formal forward guidance in the available filings. There is no explicit commentary on revenue targets, margin improvement, or capital allocation strategy beyond operational continuity. The absence of strategic updates suggests the company is in a maintenance or incremental growth phase, with no indication of a turnaround or aggressive expansion plan.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 |
| Reserves | 184 | 184 | 171 | 189 |
| Borrowings | 5 | 5 | 1 | 5 |
| Total Liabilities | 210 | 215 | 196 | 225 |
| Fixed Assets | 7 | 7 | 14 | 13 |
| Investments | 1 | 4 | 1 | 8 |
| Total Assets | 210 | 215 | 196 | 225 |
The balance sheet remains stable, with equity and reserves showing modest growth from ₹184 crore to ₹196 crore between March 2025 and March 2026, while borrowings remain minimal (₹1–5 crore). This indicates conservative leverage and a focus on preserving capital. The asset base has grown slightly, but there is no evidence of large-scale investment or asset acquisition. The company appears to be financing operations through retained earnings rather than external capital.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +3 |
| Investing | +14 |
| Financing | -20 |
| Net Cash Flow | -2 |
👥 Shareholding Pattern
| Category | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| Promoters | 65.0% | 68.1% | 68.1% |
| FII | 0.1% | 0.3% | 0.1% |
| DII | 0.0% | 0.2% | 0.2% |
| Public | 33.0% | 28.8% | 29.1% |
| # Shareholders | 35,801 | 34,558 | 33,979 |
Promoter holding has increased from 64.97% to 68.09% over the past year, indicating confidence in long-term prospects. Institutional ownership (FII and DII) remains very low, collectively under 0.5%, suggesting limited analyst or institutional coverage. The growing number of shareholders (33,979) reflects retail interest, but the lack of institutional accumulation may signal untapped upside or unaddressed risks.
⚖️ Peer Comparison — E-Commerce/App based Aggregator
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Profitability remains fragile, with alternating quarters of profit and loss, and no clear path to margin improvement. 2. Revenue growth is flat to slightly increasing, raising concerns about scalability in a competitive e-commerce landscape. 3. Low institutional interest may limit liquidity and analyst scrutiny, increasing price volatility. 4. Reliance on promoter-led growth without external validation or strategic expansion plans introduces execution risk.
📋 Recent Filings
- 🔴 Insider Trading2026-10-01Nureca Ltd disclosed on October 1, 2026, that promoter Saurabh Goyal acquired shares, but the transaction did not appear on exchange automated systems…
- 🔴 Insider Trading2026-09-30Nureca Ltd disclosed an insider trading transaction involving promoter Saurabh Goyal's purchase of shares, which was not captured by the exchange's au…
- Announcement2026-09-29Nureca Ltd announced that its trading window will close on September 29, 2026, prohibiting insiders from trading shares until 48 hours after the un-au…
- 🔴 Insider Trading2026-09-29Nureca Ltd disclosed an insider trading transaction involving promoter Saurabh Goyal's purchase of shares, which was not captured by the exchange's au…
- 🔴 Insider Trading2026-09-28Nureca disclosed an insider trading transaction involving promoter Saurabh Goyal's share purchase, which was not captured by the exchange's automated …
- 🔴 Insider Trading2026-09-26Nureca Ltd disclosed an insider trading transaction involving promoter Saurabh Goyal's share purchase, submitted manually to BSE and NSE under SEBI's …
- 🔴 Insider Trading2026-09-25Nureca disclosed that promoter Saurabh Goyal purchased shares on September 10, 2026, but these transactions did not appear on stock exchange automated…
- 🔴 Insider Trading2026-09-10Ms. Smita Goyal, a promoter group member of Nureca Limited, acquired shares of the company on September 10, 2026, as required under SEBI's PIT Regulat…
- 🔴 Insider Trading2026-09-09Ms. Smita Goyal, a promoter group member of Nureca Limited, acquired shares of the company on September 9, 2026, triggering mandatory disclosure under…
- 🔴 Insider Trading2026-08-29Nureca Limited disclosed an insider share purchase by a designated person under SEBI's PIT Regulations, Regulation 7(2), filed manually on BSE and NSE…
🧠 Analyst's Read
Nureca is in an early-stage growth phase with improving promoter confidence but lacks consistent profitability and institutional validation. Investors should monitor quarterly margins, revenue trends, and any future strategic announcements for signs of sustainable progress.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when NURECA files new disclosures
Track NURECA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NURECA — FreeFree account · 2 AI queries/day